Table 1 Clinical characteristics of cases
Clinical characteristics | Cases (n = 16) |
|---|---|
Median age (yr) at inclusion (min-max) | 27 (24–54) |
Histology | |
-Seminoma | 6 (37.5%) |
-Nonseminoma | 10 (62.5%) |
Clinical stage at diagnosis | |
-IIB | 4 (25%) |
-IIC | 3 (18.7%) |
-IIIA | 1 (6.2%) |
-IIIB | 5 (31.2%) |
-IIIC | 3 (18.7%) |
IGCCCa Risk Classification | |
-Good | 10 (62.5%) |
-Intermediate | 5 (31.2%) |
-Poor | 1 (6.2%) |
Chemotherapy regimen | |
-BEP for 3 cycles | 6 (37.5%) |
-BEP for 4 cycles | 6 (37.5%) |
-BEP for 3 cycles + TIP for 4 cycles | 1 (6.2%) |
-BEP for 4 cycles + TIP for 4 cycles | 2 (12.5%) |
-BEP for 3 cycles + VIP for 2 cycles | 1 (6.2%) |
Radiation therapy | |
-Yes | 3 (18.7%) |
Smoking | |
-Yes | 4 (25%) |
Median testosterone (ng/mL) levels (min-max) | 3.75 (1.96–4.91) |
Median time on surveillance (months) (min-max) | 26.5 (3–192) |